Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Maricann aims for growth in German medical cannabis market

Stockhouse Editorial
0 Comments| April 28, 2017

{{labelSign}}  Favorites
{{errorMessage}}

Maricann Group Inc. (CSE: MARI, Forum) has established a new subsidiary in Germany with offices located in Munich.

The new subsidiary, called Maricann GmbH, will help Maricann leverage opportunities in a large country that recently legalized medical cannabis, the company said in a press release.

More information can be found here.

Maricann was in the news recently when the shares began trading on the Canadian Securities Exchange under the symbol “MARI.” The move comes after Maricann announced that it had agreed to proceed with a reverse takeover of Danbel Ventures Inc.

The company was founded in 2013 and is based in Langton, Ont.

Full Disclosure: Maricann Group Inc. is a paid client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today